<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN"
"http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en">
<head>
<!-- 2018-12-20 Thu 17:54 -->
<meta http-equiv="Content-Type" content="text/html;charset=utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1" />
<title>&lrm;</title>
<meta name="generator" content="Org mode" />
<meta name="author" content="Zelly D. Snyder" />
<style type="text/css">
 <!--/*--><![CDATA[/*><!--*/
  .title  { text-align: center;
             margin-bottom: .2em; }
  .subtitle { text-align: center;
              font-size: medium;
              font-weight: bold;
              margin-top:0; }
  .todo   { font-family: monospace; color: red; }
  .done   { font-family: monospace; color: green; }
  .priority { font-family: monospace; color: orange; }
  .tag    { background-color: #eee; font-family: monospace;
            padding: 2px; font-size: 80%; font-weight: normal; }
  .timestamp { color: #bebebe; }
  .timestamp-kwd { color: #5f9ea0; }
  .org-right  { margin-left: auto; margin-right: 0px;  text-align: right; }
  .org-left   { margin-left: 0px;  margin-right: auto; text-align: left; }
  .org-center { margin-left: auto; margin-right: auto; text-align: center; }
  .underline { text-decoration: underline; }
  #postamble p, #preamble p { font-size: 90%; margin: .2em; }
  p.verse { margin-left: 3%; }
  pre {
    border: 1px solid #ccc;
    box-shadow: 3px 3px 3px #eee;
    padding: 8pt;
    font-family: monospace;
    overflow: auto;
    margin: 1.2em;
  }
  pre.src {
    position: relative;
    overflow: visible;
    padding-top: 1.2em;
  }
  pre.src:before {
    display: none;
    position: absolute;
    background-color: white;
    top: -10px;
    right: 10px;
    padding: 3px;
    border: 1px solid black;
  }
  pre.src:hover:before { display: inline;}
  /* Languages per Org manual */
  pre.src-asymptote:before { content: 'Asymptote'; }
  pre.src-awk:before { content: 'Awk'; }
  pre.src-C:before { content: 'C'; }
  /* pre.src-C++ doesn't work in CSS */
  pre.src-clojure:before { content: 'Clojure'; }
  pre.src-css:before { content: 'CSS'; }
  pre.src-D:before { content: 'D'; }
  pre.src-ditaa:before { content: 'ditaa'; }
  pre.src-dot:before { content: 'Graphviz'; }
  pre.src-calc:before { content: 'Emacs Calc'; }
  pre.src-emacs-lisp:before { content: 'Emacs Lisp'; }
  pre.src-fortran:before { content: 'Fortran'; }
  pre.src-gnuplot:before { content: 'gnuplot'; }
  pre.src-haskell:before { content: 'Haskell'; }
  pre.src-hledger:before { content: 'hledger'; }
  pre.src-java:before { content: 'Java'; }
  pre.src-js:before { content: 'Javascript'; }
  pre.src-latex:before { content: 'LaTeX'; }
  pre.src-ledger:before { content: 'Ledger'; }
  pre.src-lisp:before { content: 'Lisp'; }
  pre.src-lilypond:before { content: 'Lilypond'; }
  pre.src-lua:before { content: 'Lua'; }
  pre.src-matlab:before { content: 'MATLAB'; }
  pre.src-mscgen:before { content: 'Mscgen'; }
  pre.src-ocaml:before { content: 'Objective Caml'; }
  pre.src-octave:before { content: 'Octave'; }
  pre.src-org:before { content: 'Org mode'; }
  pre.src-oz:before { content: 'OZ'; }
  pre.src-plantuml:before { content: 'Plantuml'; }
  pre.src-processing:before { content: 'Processing.js'; }
  pre.src-python:before { content: 'Python'; }
  pre.src-R:before { content: 'R'; }
  pre.src-ruby:before { content: 'Ruby'; }
  pre.src-sass:before { content: 'Sass'; }
  pre.src-scheme:before { content: 'Scheme'; }
  pre.src-screen:before { content: 'Gnu Screen'; }
  pre.src-sed:before { content: 'Sed'; }
  pre.src-sh:before { content: 'shell'; }
  pre.src-sql:before { content: 'SQL'; }
  pre.src-sqlite:before { content: 'SQLite'; }
  /* additional languages in org.el's org-babel-load-languages alist */
  pre.src-forth:before { content: 'Forth'; }
  pre.src-io:before { content: 'IO'; }
  pre.src-J:before { content: 'J'; }
  pre.src-makefile:before { content: 'Makefile'; }
  pre.src-maxima:before { content: 'Maxima'; }
  pre.src-perl:before { content: 'Perl'; }
  pre.src-picolisp:before { content: 'Pico Lisp'; }
  pre.src-scala:before { content: 'Scala'; }
  pre.src-shell:before { content: 'Shell Script'; }
  pre.src-ebnf2ps:before { content: 'ebfn2ps'; }
  /* additional language identifiers per "defun org-babel-execute"
       in ob-*.el */
  pre.src-cpp:before  { content: 'C++'; }
  pre.src-abc:before  { content: 'ABC'; }
  pre.src-coq:before  { content: 'Coq'; }
  pre.src-groovy:before  { content: 'Groovy'; }
  /* additional language identifiers from org-babel-shell-names in
     ob-shell.el: ob-shell is the only babel language using a lambda to put
     the execution function name together. */
  pre.src-bash:before  { content: 'bash'; }
  pre.src-csh:before  { content: 'csh'; }
  pre.src-ash:before  { content: 'ash'; }
  pre.src-dash:before  { content: 'dash'; }
  pre.src-ksh:before  { content: 'ksh'; }
  pre.src-mksh:before  { content: 'mksh'; }
  pre.src-posh:before  { content: 'posh'; }
  /* Additional Emacs modes also supported by the LaTeX listings package */
  pre.src-ada:before { content: 'Ada'; }
  pre.src-asm:before { content: 'Assembler'; }
  pre.src-caml:before { content: 'Caml'; }
  pre.src-delphi:before { content: 'Delphi'; }
  pre.src-html:before { content: 'HTML'; }
  pre.src-idl:before { content: 'IDL'; }
  pre.src-mercury:before { content: 'Mercury'; }
  pre.src-metapost:before { content: 'MetaPost'; }
  pre.src-modula-2:before { content: 'Modula-2'; }
  pre.src-pascal:before { content: 'Pascal'; }
  pre.src-ps:before { content: 'PostScript'; }
  pre.src-prolog:before { content: 'Prolog'; }
  pre.src-simula:before { content: 'Simula'; }
  pre.src-tcl:before { content: 'tcl'; }
  pre.src-tex:before { content: 'TeX'; }
  pre.src-plain-tex:before { content: 'Plain TeX'; }
  pre.src-verilog:before { content: 'Verilog'; }
  pre.src-vhdl:before { content: 'VHDL'; }
  pre.src-xml:before { content: 'XML'; }
  pre.src-nxml:before { content: 'XML'; }
  /* add a generic configuration mode; LaTeX export needs an additional
     (add-to-list 'org-latex-listings-langs '(conf " ")) in .emacs */
  pre.src-conf:before { content: 'Configuration File'; }

  table { border-collapse:collapse; }
  caption.t-above { caption-side: top; }
  caption.t-bottom { caption-side: bottom; }
  td, th { vertical-align:top;  }
  th.org-right  { text-align: center;  }
  th.org-left   { text-align: center;   }
  th.org-center { text-align: center; }
  td.org-right  { text-align: right;  }
  td.org-left   { text-align: left;   }
  td.org-center { text-align: center; }
  dt { font-weight: bold; }
  .footpara { display: inline; }
  .footdef  { margin-bottom: 1em; }
  .figure { padding: 1em; }
  .figure p { text-align: center; }
  .inlinetask {
    padding: 10px;
    border: 2px solid gray;
    margin: 10px;
    background: #ffffcc;
  }
  #org-div-home-and-up
   { text-align: right; font-size: 70%; white-space: nowrap; }
  textarea { overflow-x: auto; }
  .linenr { font-size: smaller }
  .code-highlighted { background-color: #ffff00; }
  .org-info-js_info-navigation { border-style: none; }
  #org-info-js_console-label
    { font-size: 10px; font-weight: bold; white-space: nowrap; }
  .org-info-js_search-highlight
    { background-color: #ffff00; color: #000000; font-weight: bold; }
  .org-svg { width: 90%; }
  /*]]>*/-->
</style>
<script type="text/javascript">
/*
@licstart  The following is the entire license notice for the
JavaScript code in this tag.

Copyright (C) 2012-2018 Free Software Foundation, Inc.

The JavaScript code in this tag is free software: you can
redistribute it and/or modify it under the terms of the GNU
General Public License (GNU GPL) as published by the Free Software
Foundation, either version 3 of the License, or (at your option)
any later version.  The code is distributed WITHOUT ANY WARRANTY;
without even the implied warranty of MERCHANTABILITY or FITNESS
FOR A PARTICULAR PURPOSE.  See the GNU GPL for more details.

As additional permission under GNU GPL version 3 section 7, you
may distribute non-source (e.g., minimized or compacted) forms of
that code without the copy of the GNU GPL normally required by
section 4, provided you include this license notice and a URL
through which recipients can access the Corresponding Source.


@licend  The above is the entire license notice
for the JavaScript code in this tag.
*/
<!--/*--><![CDATA[/*><!--*/
 function CodeHighlightOn(elem, id)
 {
   var target = document.getElementById(id);
   if(null != target) {
     elem.cacheClassElem = elem.className;
     elem.cacheClassTarget = target.className;
     target.className = "code-highlighted";
     elem.className   = "code-highlighted";
   }
 }
 function CodeHighlightOff(elem, id)
 {
   var target = document.getElementById(id);
   if(elem.cacheClassElem)
     elem.className = elem.cacheClassElem;
   if(elem.cacheClassTarget)
     target.className = elem.cacheClassTarget;
 }
/*]]>*///-->
</script>
</head>
<body>
<div id="content">
<div id="table-of-contents">
<h2>Table of Contents</h2>
<div id="text-table-of-contents">
<ul>
<li><a href="#org86c8c1a">1. health care delivery in the United States</a>
<ul>
<li><a href="#org4040ca6">1.1. paradoxes</a>
<ul>
<li><a href="#org7856402">1.1.1. high costs</a></li>
</ul>
</li>
<li><a href="#org7d08630">1.2. laws</a>
<ul>
<li><a href="#org96eb726">1.2.1. hospitals</a></li>
</ul>
</li>
<li><a href="#orgf47efc5">1.3. changes from 20th century to now</a>
<ul>
<li><a href="#org72c70e7">1.3.1. health care policy</a></li>
<li><a href="#org8812bae">1.3.2. medical education</a></li>
<li><a href="#orgc6a3df2">1.3.3. pharmacy education</a></li>
<li><a href="#org477228f">1.3.4. life expectancy</a></li>
</ul>
</li>
<li><a href="#org3ababb3">1.4. around the world</a></li>
<li><a href="#orgcdc3d85">1.5. Affordable Care Act</a></li>
</ul>
</li>
<li><a href="#org839f85c">2. health care professionals</a>
<ul>
<li><a href="#org19b77bf">2.1. 5 characteristics of a profession</a></li>
<li><a href="#org05cfbc5">2.2. authorized prescribers</a>
<ul>
<li><a href="#orgf8a0307">2.2.1. independent authority</a></li>
<li><a href="#org67fefdd">2.2.2. dependent authority</a></li>
<li><a href="#org92a6f75">2.2.3. none</a></li>
<li><a href="#orge3350f3">2.2.4. scope of practice</a></li>
<li><a href="#org5f9941d">2.2.5. state dependent</a></li>
</ul>
</li>
<li><a href="#org7dde58d">2.3. education</a></li>
<li><a href="#orga4d2b1e">2.4. business and entreprenurial opportunities</a></li>
</ul>
</li>
<li><a href="#org9fdee4e">3. pharmaceutical industry</a>
<ul>
<li><a href="#org5ce2bdd">3.1. laws</a>
<ul>
<li><a href="#orgf615b9a">3.1.1. Durham Humphrey Amendment</a></li>
<li><a href="#org6033606">3.1.2. Kefauver-Harris Drug Amendments</a></li>
<li><a href="#org333bb22">3.1.3. Drug Price Competition and Patent Term Restoration Act (Waxman-Hatch)</a></li>
<li><a href="#orgd04f480">3.1.4. Medicare Prescription Drug Improvement and Modernization Act</a></li>
</ul>
</li>
<li><a href="#orgdec1205">3.2. pharma vs. biotechs</a>
<ul>
<li><a href="#orgd09471c">3.2.1. pharma</a></li>
<li><a href="#orgd4f1f94">3.2.2. biotechs</a></li>
</ul>
</li>
<li><a href="#orga2a6539">3.3. new product development</a>
<ul>
<li><a href="#org9926b2e">3.3.1. requires</a></li>
<li><a href="#orgc616e58">3.3.2. phases</a></li>
</ul>
</li>
<li><a href="#orgc2b4c46">3.4. consumer goods vs. pharmaceuticals</a></li>
<li><a href="#org7f2d3e9">3.5. who affects the ultimately dispensed product?</a></li>
<li><a href="#orgdbaff20">3.6. industry trends and challenges</a></li>
<li><a href="#orgf0b9e91">3.7. 4 Ps (pharmaceutical promotion)</a>
<ul>
<li><a href="#org6103370">3.7.1. old</a></li>
<li><a href="#orgbdbc154">3.7.2. new</a></li>
<li><a href="#orgedf7b8f">3.7.3. differences</a></li>
</ul>
</li>
<li><a href="#org602e2c0">3.8. drug distribution</a>
<ul>
<li><a href="#orgf50ffb1">3.8.1. traditioanl supply chain</a></li>
<li><a href="#org2a2f293">3.8.2. historical changes</a></li>
<li><a href="#org7887d4d">3.8.3. big 3 wholesalers</a></li>
<li><a href="#org65e5c6b">3.8.4. wholesale buying groups</a></li>
</ul>
</li>
</ul>
</li>
<li><a href="#orgc64f6b0">4. consumers of healthcare</a>
<ul>
<li><a href="#orgc8ac637">4.1. U.S. patient demographics</a></li>
<li><a href="#org384cd74">4.2. models of care</a></li>
<li><a href="#org0f2bd62">4.3. health behavior models&#xa0;&#xa0;&#xa0;<span class="tag"><span class="l">l</span></span></a>
<ul>
<li><a href="#org264099f">4.3.1. Locus of Control</a></li>
<li><a href="#org2515eb9">4.3.2. Health Belief Model</a></li>
<li><a href="#orge91675d">4.3.3. Social Cognitive Theory</a></li>
<li><a href="#org55f56e7">4.3.4. Theories of Reasoned Action and Planned Behavior</a></li>
<li><a href="#org5bf7343">4.3.5. Transtheoretical Model of Change</a></li>
</ul>
</li>
</ul>
</li>
<li><a href="#orga2b00a4">5. government and public health</a>
<ul>
<li><a href="#org35d5006">5.1. top of org chart</a></li>
<li><a href="#org9e40592">5.2. Health &amp; Human Services budget allocation</a></li>
<li><a href="#org94fc964">5.3. FDA</a></li>
<li><a href="#orgd82b014">5.4. Healthy People 2020</a></li>
</ul>
</li>
<li><a href="#org35d2c10">6. economics</a>
<ul>
<li><a href="#org2048661">6.1. demand</a>
<ul>
<li><a href="#org7519471">6.1.1. factors that change demand</a></li>
<li><a href="#org976bf78">6.1.2. elasticity (2 questions)</a></li>
<li><a href="#org6100c3b">6.1.3. perfectly competitive market</a></li>
<li><a href="#orgcb0347d">6.1.4. improving healthcare</a></li>
</ul>
</li>
<li><a href="#orgdbffa58">6.2. pharmacoeconomics</a>
<ul>
<li><a href="#orge07866a">6.2.1. goal</a></li>
<li><a href="#orgcf345ca">6.2.2. cost</a></li>
<li><a href="#org2c0e49f">6.2.3. outcome</a></li>
<li><a href="#orgee0a3d0">6.2.4. ECHO</a></li>
<li><a href="#orga44ec09">6.2.5. pharmacoeconomic evaluations</a></li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
</div>
<div id="outline-container-org86c8c1a" class="outline-2">
<h2 id="org86c8c1a"><span class="section-number-2">1</span> health care delivery in the United States</h2>
<div class="outline-text-2" id="text-1">
</div>
<div id="outline-container-org4040ca6" class="outline-3">
<h3 id="org4040ca6"><span class="section-number-3">1.1</span> paradoxes</h3>
<div class="outline-text-3" id="text-1-1">
</div>
<div id="outline-container-org7856402" class="outline-4">
<h4 id="org7856402"><span class="section-number-4">1.1.1</span> high costs</h4>
<div class="outline-text-4" id="text-1-1-1">
<ul class="org-ul">
<li>High spending on health care technologies</li>
<li>Aging population</li>
<li>Increased insurance coverage</li>
<li>Decreased out-of-pocket</li>
<li>Waste, fraud, and abuse</li>
</ul>
</div>
</div>
</div>
<div id="outline-container-org7d08630" class="outline-3">
<h3 id="org7d08630"><span class="section-number-3">1.2</span> laws</h3>
<div class="outline-text-3" id="text-1-2">
</div>
<div id="outline-container-org96eb726" class="outline-4">
<h4 id="org96eb726"><span class="section-number-4">1.2.1</span> hospitals</h4>
<div class="outline-text-4" id="text-1-2-1">
<p>
Hill-Burton Act; grants for hospital growth
</p>
</div>
</div>
</div>
<div id="outline-container-orgf47efc5" class="outline-3">
<h3 id="orgf47efc5"><span class="section-number-3">1.3</span> changes from 20th century to now</h3>
<div class="outline-text-3" id="text-1-3">
</div>
<div id="outline-container-org72c70e7" class="outline-4">
<h4 id="org72c70e7"><span class="section-number-4">1.3.1</span> health care policy</h4>
<div class="outline-text-4" id="text-1-3-1">
<ul class="org-ul">
<li>increased dependence on third-party payments</li>
<li>tax deductions to employers offering health insurance (but not to individuals)</li>
</ul>
</div>
<ol class="org-ol">
<li><a id="org06663b7"></a>public vs. private<br />
<div class="outline-text-5" id="text-1-3-1-1">
<p>
less options for public sector health care
</p>
</div>
</li>
</ol>
</div>
<div id="outline-container-org8812bae" class="outline-4">
<h4 id="org8812bae"><span class="section-number-4">1.3.2</span> medical education</h4>
<div class="outline-text-4" id="text-1-3-2">
<p>
Flexner Report created higher accreditation standards for medical schools
</p>
</div>
</div>
<div id="outline-container-orgc6a3df2" class="outline-4">
<h4 id="orgc6a3df2"><span class="section-number-4">1.3.3</span> pharmacy education</h4>
<div class="outline-text-4" id="text-1-3-3">
<p>
6 year PharmD curriculum for all new students after 2000
</p>
</div>
</div>
<div id="outline-container-org477228f" class="outline-4">
<h4 id="org477228f"><span class="section-number-4">1.3.4</span> life expectancy</h4>
<div class="outline-text-4" id="text-1-3-4">
<p>
increased almost 60% because of:
</p>
<ul class="org-ul">
<li>improved standard of living
<ul class="org-ul">
<li>hygiene</li>
<li>nutrition/diet</li>
<li>housing</li>
</ul></li>
<li>advances in public health</li>
<li>progress in medical practice</li>
</ul>
</div>
</div>
</div>
<div id="outline-container-org3ababb3" class="outline-3">
<h3 id="org3ababb3"><span class="section-number-3">1.4</span> around the world</h3>
<div class="outline-text-3" id="text-1-4">
<ul class="org-ul">
<li>USA has the lowest life expectancy among comparable countries</li>
<li><a href="https://www.healthsystemtracker.org/dashboard/">Indicators of quality</a></li>
</ul>
</div>
</div>
<div id="outline-container-orgcdc3d85" class="outline-3">
<h3 id="orgcdc3d85"><span class="section-number-3">1.5</span> Affordable Care Act</h3>
<div class="outline-text-3" id="text-1-5">
<ul class="org-ul">
<li>decrease in number of uninsured</li>
<li>Must obtain at least a minimum amount of health insurance or pay a penalty</li>
<li>Private, individually, Medicaid, subsidies</li>
<li>Change in health insurance performance activities</li>
<li>Established insurance exchanges on a state basis</li>
<li>Expansion of the Medicaid program</li>
</ul>
</div>
</div>
</div>
<div id="outline-container-org839f85c" class="outline-2">
<h2 id="org839f85c"><span class="section-number-2">2</span> health care professionals</h2>
<div class="outline-text-2" id="text-2">
</div>
<div id="outline-container-org19b77bf" class="outline-3">
<h3 id="org19b77bf"><span class="section-number-3">2.1</span> 5 characteristics of a profession</h3>
<div class="outline-text-3" id="text-2-1">
<ol class="org-ol">
<li>Systematic  theory and body of knowledge</li>
<li>Professional authority and special privileges</li>
<li>Community sanction and social utility</li>
<li>Ethical codes and internal control</li>
<li>Professional culture and organizations</li>
</ol>
</div>
</div>
<div id="outline-container-org05cfbc5" class="outline-3">
<h3 id="org05cfbc5"><span class="section-number-3">2.2</span> authorized prescribers</h3>
<div class="outline-text-3" id="text-2-2">
</div>
<div id="outline-container-orgf8a0307" class="outline-4">
<h4 id="orgf8a0307"><span class="section-number-4">2.2.1</span> independent authority</h4>
<div class="outline-text-4" id="text-2-2-1">
<ul class="org-ul">
<li>MD</li>
<li>DO</li>
<li>podiatrist</li>
<li>DDS, DMD</li>
<li>DVM</li>
<li>optometrist</li>
</ul>
</div>
</div>
<div id="outline-container-org67fefdd" class="outline-4">
<h4 id="org67fefdd"><span class="section-number-4">2.2.2</span> dependent authority</h4>
<div class="outline-text-4" id="text-2-2-2">
<ul class="org-ul">
<li>nurse practitioner</li>
<li>PA</li>
<li>certified nurse midwife</li>
</ul>
</div>
</div>
<div id="outline-container-org92a6f75" class="outline-4">
<h4 id="org92a6f75"><span class="section-number-4">2.2.3</span> none</h4>
<div class="outline-text-4" id="text-2-2-3">
<ul class="org-ul">
<li>DC (chiropractor)</li>
</ul>
</div>
</div>
<div id="outline-container-orge3350f3" class="outline-4">
<h4 id="orge3350f3"><span class="section-number-4">2.2.4</span> scope of practice</h4>
<div class="outline-text-4" id="text-2-2-4">
<ul class="org-ul">
<li>podiatrist</li>
<li>dentist</li>
<li>veterinarian</li>
</ul>
</div>
</div>
<div id="outline-container-org5f9941d" class="outline-4">
<h4 id="org5f9941d"><span class="section-number-4">2.2.5</span> state dependent</h4>
<div class="outline-text-4" id="text-2-2-5">
<ul class="org-ul">
<li>optometrist</li>
</ul>
</div>
</div>
</div>
<div id="outline-container-org7dde58d" class="outline-3">
<h3 id="org7dde58d"><span class="section-number-3">2.3</span> education</h3>
<div class="outline-text-3" id="text-2-3">
<ul class="org-ul">
<li>more education leads to more direct patient care</li>
</ul>
</div>
</div>
<div id="outline-container-orga4d2b1e" class="outline-3">
<h3 id="orga4d2b1e"><span class="section-number-3">2.4</span> business and entreprenurial opportunities</h3>
<div class="outline-text-3" id="text-2-4">
<ul class="org-ul">
<li>indpendent pharmacies</li>
<li>speaking</li>
<li>MTM</li>
<li>web-based business</li>
</ul>
</div>
</div>
</div>
<div id="outline-container-org9fdee4e" class="outline-2">
<h2 id="org9fdee4e"><span class="section-number-2">3</span> pharmaceutical industry</h2>
<div class="outline-text-2" id="text-3">
</div>
<div id="outline-container-org5ce2bdd" class="outline-3">
<h3 id="org5ce2bdd"><span class="section-number-3">3.1</span> laws</h3>
<div class="outline-text-3" id="text-3-1">
</div>
<div id="outline-container-orgf615b9a" class="outline-4">
<h4 id="orgf615b9a"><span class="section-number-4">3.1.1</span> Durham Humphrey Amendment</h4>
<div class="outline-text-4" id="text-3-1-1">
<p>
created prescriptions
</p>
</div>
</div>
<div id="outline-container-org6033606" class="outline-4">
<h4 id="org6033606"><span class="section-number-4">3.1.2</span> Kefauver-Harris Drug Amendments</h4>
<div class="outline-text-4" id="text-3-1-2">
<p>
manufacturers must prove safety and efficacy to the FDA
</p>
</div>
</div>
<div id="outline-container-org333bb22" class="outline-4">
<h4 id="org333bb22"><span class="section-number-4">3.1.3</span> Drug Price Competition and Patent Term Restoration Act (Waxman-Hatch)</h4>
<div class="outline-text-4" id="text-3-1-3">
<p>
FDA approves cheap generics without having to repeat safety and efficacy trials
</p>
</div>
</div>
<div id="outline-container-orgd04f480" class="outline-4">
<h4 id="orgd04f480"><span class="section-number-4">3.1.4</span> Medicare Prescription Drug Improvement and Modernization Act</h4>
<div class="outline-text-4" id="text-3-1-4">
<p>
Medicaire Part D
</p>
</div>
</div>
</div>
<div id="outline-container-orgdec1205" class="outline-3">
<h3 id="orgdec1205"><span class="section-number-3">3.2</span> pharma vs. biotechs</h3>
<div class="outline-text-3" id="text-3-2">
</div>
<div id="outline-container-orgd09471c" class="outline-4">
<h4 id="orgd09471c"><span class="section-number-4">3.2.1</span> pharma</h4>
<div class="outline-text-4" id="text-3-2-1">
<ul class="org-ul">
<li>larger R&amp;D budgets</li>
<li>beauraucratic large companies; well-defined career ladders</li>
<li>higher salaries/benefits</li>
</ul>
</div>
</div>
<div id="outline-container-orgd4f1f94" class="outline-4">
<h4 id="orgd4f1f94"><span class="section-number-4">3.2.2</span> biotechs</h4>
<div class="outline-text-4" id="text-3-2-2">
<ul class="org-ul">
<li>fast-paced research</li>
<li>lower salaries/benefits</li>
<li>less bureaucracy</li>
</ul>
</div>
</div>
</div>
<div id="outline-container-orga2a6539" class="outline-3">
<h3 id="orga2a6539"><span class="section-number-3">3.3</span> new product development</h3>
<div class="outline-text-3" id="text-3-3">
</div>
<div id="outline-container-org9926b2e" class="outline-4">
<h4 id="org9926b2e"><span class="section-number-4">3.3.1</span> requires</h4>
<div class="outline-text-4" id="text-3-3-1">
<ul class="org-ul">
<li>time</li>
<li>money</li>
<li>effort</li>
</ul>
</div>
</div>
<div id="outline-container-orgc616e58" class="outline-4">
<h4 id="orgc616e58"><span class="section-number-4">3.3.2</span> phases</h4>
<div class="outline-text-4" id="text-3-3-2">
<ol class="org-ol">
<li>patient volunteers used to determine <i>safety and dosage</i></li>
<li>patient volunteers used to look for <i>efficacy and side effects</i></li>
<li>patient volunteers used to monitor <i>adverse reactions to long-term use</i></li>
<li>FDA approval, post-marketing, and testing</li>
</ol>
</div>
</div>
</div>
<div id="outline-container-orgc2b4c46" class="outline-3">
<h3 id="orgc2b4c46"><span class="section-number-3">3.4</span> consumer goods vs. pharmaceuticals</h3>
<div class="outline-text-3" id="text-3-4">
<p>
requires prescription
</p>
</div>
</div>
<div id="outline-container-org7f2d3e9" class="outline-3">
<h3 id="org7f2d3e9"><span class="section-number-3">3.5</span> who affects the ultimately dispensed product?</h3>
<div class="outline-text-3" id="text-3-5">
<ul class="org-ul">
<li>consumer</li>
<li>3rd party payer</li>
<li>wholesaler</li>
<li>pharmacy</li>
<li>prescriber</li>
</ul>
</div>
</div>
<div id="outline-container-orgdbaff20" class="outline-3">
<h3 id="orgdbaff20"><span class="section-number-3">3.6</span> industry trends and challenges</h3>
<div class="outline-text-3" id="text-3-6">
<ul class="org-ul">
<li>competition → consolidation</li>
<li>counterfeiting</li>
</ul>
</div>
</div>
<div id="outline-container-orgf0b9e91" class="outline-3">
<h3 id="orgf0b9e91"><span class="section-number-3">3.7</span> 4 Ps (pharmaceutical promotion)</h3>
<div class="outline-text-3" id="text-3-7">
</div>
<div id="outline-container-org6103370" class="outline-4">
<h4 id="org6103370"><span class="section-number-4">3.7.1</span> old</h4>
<div class="outline-text-4" id="text-3-7-1">
<ul class="org-ul">
<li>Product</li>
<li>Price</li>
<li>Place</li>
<li>Promotion</li>
</ul>
</div>
</div>
<div id="outline-container-orgbdbc154" class="outline-4">
<h4 id="orgbdbc154"><span class="section-number-4">3.7.2</span> new</h4>
<div class="outline-text-4" id="text-3-7-2">
<ul class="org-ul">
<li>Predictive Modeling</li>
<li>Personalization</li>
<li>Peer-to-Peer</li>
<li>Participation</li>
</ul>
</div>
</div>
<div id="outline-container-orgedf7b8f" class="outline-4">
<h4 id="orgedf7b8f"><span class="section-number-4">3.7.3</span> differences</h4>
<div class="outline-text-4" id="text-3-7-3">
</div>
<ol class="org-ol">
<li><a id="org72cd670"></a>old<br />
<div class="outline-text-5" id="text-3-7-3-1">
<ul class="org-ul">
<li>Brand-focused</li>
<li>Capital intensive</li>
<li>Technology-enabled (?)</li>
<li>Longer development</li>
<li>Slower to modify</li>
</ul>
</div>
</li>
<li><a id="org73578ca"></a>new<br />
<div class="outline-text-5" id="text-3-7-3-2">
<ul class="org-ul">
<li>Customer-focused</li>
<li>Budget conscious</li>
<li>Technology-powered (?)</li>
<li>Quickly deployed</li>
<li>Highly optimized</li>
</ul>
</div>
</li>
</ol>
</div>
</div>
<div id="outline-container-org602e2c0" class="outline-3">
<h3 id="org602e2c0"><span class="section-number-3">3.8</span> drug distribution</h3>
<div class="outline-text-3" id="text-3-8">
</div>
<div id="outline-container-orgf50ffb1" class="outline-4">
<h4 id="orgf50ffb1"><span class="section-number-4">3.8.1</span> traditioanl supply chain</h4>
<div class="outline-text-4" id="text-3-8-1">
<ol class="org-ol">
<li>manufacturer</li>
<li>wholesaler</li>
<li>pharmacy</li>
<li>patient</li>
</ol>
</div>
</div>
<div id="outline-container-org2a2f293" class="outline-4">
<h4 id="org2a2f293"><span class="section-number-4">3.8.2</span> historical changes</h4>
<div class="outline-text-4" id="text-3-8-2">
</div>
<ol class="org-ol">
<li><a id="org19048aa"></a>1960s<br />
<div class="outline-text-5" id="text-3-8-2-1">
<ul class="org-ul">
<li>wholesaler pricing was “list less”—average wholesale price minus a discount used to drive business</li>
<li>wholesalers only did <i>pick, pack, and ship</i></li>
</ul>
</div>
</li>
<li><a id="orga9203fd"></a>1980s<br />
<div class="outline-text-5" id="text-3-8-2-2">
<p>
“cost plus”—average wholesale price <i>plus</i> a percentage
</p>
</div>
</li>
<li><a id="orgca50fc6"></a>1990s<br />
<div class="outline-text-5" id="text-3-8-2-3">
<ul class="org-ul">
<li>price erosion</li>
<li>wholesaler consolidations</li>
</ul>
</div>
</li>
</ol>
</div>
<div id="outline-container-org7887d4d" class="outline-4">
<h4 id="org7887d4d"><span class="section-number-4">3.8.3</span> big 3 wholesalers</h4>
<div class="outline-text-4" id="text-3-8-3">
<ul class="org-ul">
<li>AmerisourceBergen (ABC)</li>
<li>Cardinal Health</li>
<li>McKesson</li>
</ul>
</div>
</div>
<div id="outline-container-org65e5c6b" class="outline-4">
<h4 id="org65e5c6b"><span class="section-number-4">3.8.4</span> wholesale buying groups</h4>
<div class="outline-text-4" id="text-3-8-4">
<ul class="org-ul">
<li>exist to increase <i>buying power</i></li>
<li>more than 80% of independent pharmacies pool together to purchase medications</li>
</ul>
</div>
</div>
</div>
</div>
<div id="outline-container-orgc64f6b0" class="outline-2">
<h2 id="orgc64f6b0"><span class="section-number-2">4</span> consumers of healthcare</h2>
<div class="outline-text-2" id="text-4">
</div>
<div id="outline-container-orgc8ac637" class="outline-3">
<h3 id="orgc8ac637"><span class="section-number-3">4.1</span> U.S. patient demographics</h3>
<div class="outline-text-3" id="text-4-1">
<ul class="org-ul">
<li>older</li>
<li>fastest growing segment is &gt;85</li>
</ul>
</div>
</div>
<div id="outline-container-org384cd74" class="outline-3">
<h3 id="org384cd74"><span class="section-number-3">4.2</span> models of care</h3>
<div class="outline-text-3" id="text-4-2">
<ul class="org-ul">
<li>Consumer model</li>
<li>Patient-centered model</li>
<li>Biopsychosocial model</li>
</ul>
</div>
</div>
<div id="outline-container-org0f2bd62" class="outline-3">
<h3 id="org0f2bd62"><span class="section-number-3">4.3</span> health behavior models&#xa0;&#xa0;&#xa0;<span class="tag"><span class="l">l</span></span></h3>
<div class="outline-text-3" id="text-4-3">
</div>
<div id="outline-container-org264099f" class="outline-4">
<h4 id="org264099f"><span class="section-number-4">4.3.1</span> Locus of Control</h4>
<div class="outline-text-4" id="text-4-3-1">
<p>
Attainment of a particular outcome is either within one’s control or outside of it.
</p>
</div>
</div>
<div id="outline-container-org2515eb9" class="outline-4">
<h4 id="org2515eb9"><span class="section-number-4">4.3.2</span> Health Belief Model</h4>
<div class="outline-text-4" id="text-4-3-2">
<p>
Likelihood that one will take action or change behavior.
</p>
</div>
</div>
<div id="outline-container-orge91675d" class="outline-4">
<h4 id="orge91675d"><span class="section-number-4">4.3.3</span> Social Cognitive Theory</h4>
<div class="outline-text-4" id="text-4-3-3">
<ul class="org-ul">
<li>outcome expectation—belief that a behavior will have some outcome</li>
<li>efficacy expectation—belief that one will be able to change
<ul class="org-ul">
<li>Performance accomplishments</li>
<li>Vicarious experience</li>
<li>Verbal persuasion</li>
<li>Physiological state</li>
</ul></li>
</ul>
</div>
</div>
<div id="outline-container-org55f56e7" class="outline-4">
<h4 id="org55f56e7"><span class="section-number-4">4.3.4</span> Theories of Reasoned Action and Planned Behavior</h4>
</div>
<div id="outline-container-org5bf7343" class="outline-4">
<h4 id="org5bf7343"><span class="section-number-4">4.3.5</span> Transtheoretical Model of Change</h4>
<div class="outline-text-4" id="text-4-3-5">
<p>
stages:
</p>
<ol class="org-ol">
<li>Pre-contemplation</li>
<li>Contemplation</li>
<li>Preparation</li>
<li>Action</li>
<li>Maintenance</li>
</ol>
</div>
</div>
</div>
</div>
<div id="outline-container-orga2b00a4" class="outline-2">
<h2 id="orga2b00a4"><span class="section-number-2">5</span> government and public health</h2>
<div class="outline-text-2" id="text-5">
</div>
<div id="outline-container-org35d5006" class="outline-3">
<h3 id="org35d5006"><span class="section-number-3">5.1</span> top of org chart</h3>
<div class="outline-text-3" id="text-5-1">
<p>
Health &amp; Human Services
</p>
</div>
</div>
<div id="outline-container-org9e40592" class="outline-3">
<h3 id="org9e40592"><span class="section-number-3">5.2</span> Health &amp; Human Services budget allocation</h3>
<div class="outline-text-3" id="text-5-2">
<ol class="org-ol">
<li>Medicaire and Medicaid</li>
<li>Administration for Children and Families</li>
<li>NIH</li>
<li>Health Resources and Services</li>
<li>FDA, CDC, …</li>
</ol>
</div>
</div>
<div id="outline-container-org94fc964" class="outline-3">
<h3 id="org94fc964"><span class="section-number-3">5.3</span> FDA</h3>
<div class="outline-text-3" id="text-5-3">
<p>
<a href="http://www.fda.gov/AboutFDA/WhatWeDo/default.htm">FDA responsibilites</a>
</p>
</div>
</div>
<div id="outline-container-orgd82b014" class="outline-3">
<h3 id="orgd82b014"><span class="section-number-3">5.4</span> Healthy People 2020</h3>
<div class="outline-text-3" id="text-5-4">
<ul class="org-ul">
<li>Provides comprehensive framework for health promotion and disease prevention</li>
<li>Tracking of data-driven outcomes to monitor progress</li>
<li>Engages a multi-disciplinary network of stakeholders</li>
<li>Guides national research on public health</li>
<li>Establishes accountability – must demonstrate support  of Health People objectives for grants</li>
</ul>
</div>
</div>
</div>
<div id="outline-container-org35d2c10" class="outline-2">
<h2 id="org35d2c10"><span class="section-number-2">6</span> economics</h2>
<div class="outline-text-2" id="text-6">
</div>
<div id="outline-container-org2048661" class="outline-3">
<h3 id="org2048661"><span class="section-number-3">6.1</span> demand</h3>
<div class="outline-text-3" id="text-6-1">
<p>
amounts of a commodity that consumers are <i>willing and able</i> to purchase at a set of possible prices over a specified period of time
</p>
</div>
<div id="outline-container-org7519471" class="outline-4">
<h4 id="org7519471"><span class="section-number-4">6.1.1</span> factors that change demand</h4>
<div class="outline-text-4" id="text-6-1-1">
<ul class="org-ul">
<li>prices of related goods
<ul class="org-ul">
<li>substitutes</li>
<li>complements</li>
</ul></li>
<li>income of consumer</li>
<li>number of other consumers in the market</li>
<li>attitudes, tastes, and preferences of the consumer</li>
<li>consumer expectations of future prices or future income</li>
</ul>
</div>
</div>
<div id="outline-container-org976bf78" class="outline-4">
<h4 id="org976bf78"><span class="section-number-4">6.1.2</span> elasticity (2 questions)</h4>
<div class="outline-text-4" id="text-6-1-2">
<p>
the responsiveness of consumer demands to a change in price
</p>
</div>
<ol class="org-ol">
<li><a id="org21ed5bd"></a>types&#xa0;&#xa0;&#xa0;<span class="tag"><span class="l">l</span></span><br />
<ol class="org-ol">
<li><a id="orgc5b949d"></a>elastic demand<br />
<div class="outline-text-6" id="text-6-1-2-1-1">
<p>
increase in price ⇒ decrease in revenue
</p>
</div>
</li>
<li><a id="org8c169b9"></a>inelastic demand<br />
<div class="outline-text-6" id="text-6-1-2-1-2">
<p>
increase in price ⇒ revenue still increases
</p>
</div>
</li>
<li><a id="orgaf378ca"></a>unitary demand<br />
<div class="outline-text-6" id="text-6-1-2-1-3">
<ul class="org-ul">
<li>price changes ⇒ revenue doesn’t change</li>
<li>doesn’t happen in the real world</li>
</ul>
</div>
</li>
</ol>
</li>
<li><a id="orgb267df5"></a>healthcare costs that a patient must pay out of pocket—elastic or inelastic?<br />
<div class="outline-text-5" id="text-6-1-2-2">
<p>
elastic; the patient often foregoes treatment
</p>
</div>
</li>
</ol>
</div>
<div id="outline-container-org6100c3b" class="outline-4">
<h4 id="org6100c3b"><span class="section-number-4">6.1.3</span> perfectly competitive market</h4>
<div class="outline-text-4" id="text-6-1-3">
</div>
<ol class="org-ol">
<li><a id="org4678844"></a>characteristics<br />
<div class="outline-text-5" id="text-6-1-3-1">
<ul class="org-ul">
<li>many buyers and sellers</li>
<li>freedom of entry and exit</li>
<li>standardized products</li>
<li>free information</li>
<li>no collusion</li>
</ul>
</div>
</li>
<li><a id="orge38b383"></a>healthcare<br />
<div class="outline-text-5" id="text-6-1-3-2">
<p>
healthcare is not a perfectly competitive market:
</p>
<ul class="org-ul">
<li>consolidation among sellers and buyers; maldistribution of supply</li>
<li>high barriers to entry for suppliers (e.g., healthcare providers, manufacturers)</li>
<li>care is individualized, inconsistent, and difficult to measure; so the “product” is not standardized</li>
</ul>
</div>
</li>
</ol>
</div>
<div id="outline-container-orgcb0347d" class="outline-4">
<h4 id="orgcb0347d"><span class="section-number-4">6.1.4</span> improving healthcare</h4>
<div class="outline-text-4" id="text-6-1-4">
<ul class="org-ul">
<li>healthcare as a public utility</li>
<li>improve costs and quality
<ul class="org-ul">
<li>pay for performance</li>
<li>tiered cost sharing</li>
</ul></li>
<li>create incentives</li>
</ul>
</div>
</div>
</div>
<div id="outline-container-orgdbffa58" class="outline-3">
<h3 id="orgdbffa58"><span class="section-number-3">6.2</span> pharmacoeconomics</h3>
<div class="outline-text-3" id="text-6-2">
</div>
<div id="outline-container-orge07866a" class="outline-4">
<h4 id="orge07866a"><span class="section-number-4">6.2.1</span> goal</h4>
<div class="outline-text-4" id="text-6-2-1">
<p>
outcomes outweigh costs
</p>
</div>
</div>
<div id="outline-container-orgcf345ca" class="outline-4">
<h4 id="orgcf345ca"><span class="section-number-4">6.2.2</span> cost</h4>
<div class="outline-text-4" id="text-6-2-2">
</div>
<ol class="org-ol">
<li><a id="org560c6f5"></a>economic cost<br />
<div class="outline-text-5" id="text-6-2-2-1">
<p>
the consumption of a resource that could otherwise be used for another purpose
</p>
</div>
</li>
<li><a id="orgb48d181"></a>opportunity cost<br />
<div class="outline-text-5" id="text-6-2-2-2">
<p>
value of the benefits foregone because the resource is not available for its best alternative
</p>
</div>
</li>
<li><a id="org71f89f2"></a>direct medical costs<br />
<div class="outline-text-5" id="text-6-2-2-3">
<p>
e.g., physician fees, X-ray costs, prescription costs
</p>
</div>
</li>
<li><a id="orgf1718a7"></a>direct non-medical costs<br />
<div class="outline-text-5" id="text-6-2-2-4">
<p>
e.g., transportation to healthcare providers, specific diet
</p>
</div>
</li>
<li><a id="org0e06bf0"></a>indirect costs<br />
<div class="outline-text-5" id="text-6-2-2-5">
<ul class="org-ul">
<li>loss in productivity due to morbidity and mortality due to disease</li>
<li>hard to measure</li>
</ul>
</div>
</li>
<li><a id="orgf4eeace"></a>intangible costs<br />
<div class="outline-text-5" id="text-6-2-2-6">
<ul class="org-ul">
<li>“emotional stress, fear, anxiety, psychological effects”</li>
<li>hardest to measure</li>
</ul>
</div>
</li>
</ol>
</div>
<div id="outline-container-org2c0e49f" class="outline-4">
<h4 id="org2c0e49f"><span class="section-number-4">6.2.3</span> outcome</h4>
<div class="outline-text-4" id="text-6-2-3">
</div>
<ol class="org-ol">
<li><a id="org88982a7"></a>types<br />
<ol class="org-ol">
<li><a id="org43a2794"></a>structure outcomes<br /></li>
<li><a id="org74aff4e"></a>process outcomes<br />
<div class="outline-text-6" id="text-6-2-3-1-2">
<p>
e.g., accuracy of directions on prescription label
</p>
</div>
</li>
<li><a id="org935a23d"></a>clinical outcomes<br />
<div class="outline-text-6" id="text-6-2-3-1-3">
<ul class="org-ul">
<li>safety and efficacy</li>
<li>uses intermediate measures as proxy indicators of outcomes; e.g., INR is the outcome for warfarin instead of strokes because strokes are unpredictable</li>
</ul>
</div>
</li>
<li><a id="orgb6dd8bf"></a>economic outcomes<br />
<div class="outline-text-6" id="text-6-2-3-1-4">
<p>
healthcare expenditures
</p>
</div>
</li>
</ol>
</li>
</ol>
</div>
<div id="outline-container-orgee0a3d0" class="outline-4">
<h4 id="orgee0a3d0"><span class="section-number-4">6.2.4</span> ECHO</h4>
<div class="outline-text-4" id="text-6-2-4">
<p>
“Economic Clincial Humanistic Outcomes” model
</p>
</div>
</div>
<div id="outline-container-orga44ec09" class="outline-4">
<h4 id="orga44ec09"><span class="section-number-4">6.2.5</span> pharmacoeconomic evaluations</h4>
<div class="outline-text-4" id="text-6-2-5">
<p>
<a href="https://cdn.pbrd.co/images/HSFpYnF.png">Know slide #16 from Pharmacoeconomics</a>
</p>
</div>
</div>
</div>
</div>
</div>
</body>
</html>
